Ribazole 400mg Capsule
Ribazole 400mg Capsule
Pack Size: 10’s
Composition : Ribavirin
Pharmaceutical form: capsule
Brand Name: [button link=”https://www.almishkat.pk” color=”red” newwindow=”yes”] GETZ[/button]
- Additional Information
- Reviews (0)
Ki Ribazole 400mg Capsule
Ki Ribazole 400mg Capsule (Ribavirin) is a synthetic nucleoside analogue (purine analogue) with antiviral activity. The chemical name of ribavirin is 1-ß-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide.Ki Ribazole 400mg Capsule molecular formula is C8H12N4O5. Before taking ribavirin, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: blood disorders (e.g., sickle cell anemia, low hemoglobin, thalassemia), kidney disease, other liver problems (e.g., autoimmune hepatitis), heart disease, high blood pressure, breathing problems, pancreas problems (e.g., pancreatitis), diabetes.
This drug may make you dizzy or unusually tired or blur your vision. Drug interactions may change how your medications work or increase your risk for serious side effects.
Ribavirin is used in combination with other antiviral medications (such as interferon, sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. Ribavirin works by reducing the amount of hepatitis C virus in your body, which may help your liver recover.
Nausea, diarrhea, stomach upset, headache, dizziness, blurred vision, trouble sleeping, cough, low appetite, weight loss or gain, dry skin, or changes in taste/hearing may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly
When not use
No cases of overdose with ribavirin have been reported. Hypocalcemia and hypomagnesemia have been observed in persons administered greater than the recommended dosages of ribavirin. In most of these cases, ribavirin was administered intravenously at dosage up to and in some cases exceeding four times the recommended maximum oral daily dose.
There are no reviews yet.